OphthalmoPro provides clinicians with advanced technologies that support the detection and management of macular disease.
The new Microclear SKY Whole Eye imaging system delivers comprehensive retinal imaging with high-resolution visualisation of the posterior segment, in the form of widefield fundus photography (135°) combined with widefield optical coherence tomography, assisting clinicians in identifying structural changes associated with macular conditions such as age-related macular degeneration (AMD).
Complementing these diagnostic capabilities, Espansione’s AMD Eye-light device is now officially available in New Zealand, offering photobiomodulation light-based therapy for the management of early to intermediate dry AMD. Together, these technologies support a more integrated approach to macular care, enabling improved screening, monitoring, and non-invasive treatment pathways.
By combining advanced imaging with emerging therapeutic options, OphthalmoPro aims to support earlier detection and improve clinical management of macular disease.
Contact: Ophthalmopro (AUS) 1300 578 288 or (NZ) 0800 578 288 or visit ophthalmopro.com.au
